BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Thomas Flaten does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 BDSXBiodesix Inc | Buy | $2.00 | May 2025 | +222.2% | Miss |
 CSTLCastle Biosciences Inc | Buy | $35.00 | May 2025 | +35.8% | Hit |
 AQSTAquestive Therapeutics Inc | Buy | $8.00 | Mar 2025 | +62.6% | Miss |
 PSNLPersonalis Inc | Buy | $9.00 | Jan 2025 | +34.6% | Hit |
| CSTLCastle Biosciences Inc | Buy | $40.00 | Nov 2024 | +2.6% | Miss |
 DERMJourney Medical Corp | Buy | $9.00 | Sep 2024 | +54.7% | Miss |
 ASRTAssertio Therapeutics Inc | Buy | $3.00 | Mar 2024 | −32.0% | Miss |
 ACHVAchieve Life Sciences Inc | Buy | $11.00 | Mar 2024 | −39.1% | Miss |
| ACHVAchieve Life Sciences Inc | Buy | $19.00 | May 2023 | −29.8% | Miss |
| ACHVAchieve Life Sciences Inc | Buy | $22.00 | May 2023 | −59.0% | Miss |
| ASRTAssertio Therapeutics Inc | Buy | $9.00 | May 2023 | −96.3% | Miss |
 EVAXEvaxion Biotech AS | Buy | $7.00 | Mar 2023 | −85.4% | Miss |
 ENSCEnsysce Biosciences Inc | Buy | $8.00 | Nov 2022 | −93.2% | Miss |
| ASRTAssertio Therapeutics Inc | Buy | $7.00 | Nov 2022 | −13.4% | Hit |
 DMACDiaMedica Therapeutics Inc | Buy | $8.00 | Jul 2022 | +190.8% | Miss |
| ENSCEnsysce Biosciences Inc | Buy | $4.00 | Nov 2021 | −99.1% | Hit |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.